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ABSTRACT
￿
The distribution of Man-6-P receptors was determined by immunoperoxidase cytochem-
istry in Clone 9 hepatocytes cultured in the presence or absence of tunicamycin and chloroquine,
agents that perturb lysosomal enzyme sorting and lead to their secretion . In control (untreated) cells,
receptors were localized in cis Golgi cisternae, coated vesicles, and in endosomes or lysosomes.
After tunicamycin treatment, receptors were found in coated vesicles lined up along the cis cisternae
but were not detected in endosomes or lysosomes. After chloroquine treatment, receptors were
localized in large vacuolated endosomes or lysosomes but were not usually detected in Golgi
cisternae or in coated vesicles . These results demonstrate a redistribution of receptors along the
normal Man-6-P-dependent sorting pathway after these treatments . In ligand-deficient (tunicamycin-
treated) cells, immunoreactive receptors accumulate at the presumptive sorting site in the cis Golgi
and are depleted from endosomes and lysosomes. When the intralysosomal pH is increased (by
chloroquine treatment) preventing ligand-receptor dissociation, receptors accumulate at the pre-
sumptive delivery site (lysosomes and endosomes) and are depleted from the cis Golgi region. The
findings also suggest that (a) ligand binding triggers movement of the receptor to endosomes or
lysosomes, and (b) ligand dissociation triggers their movement back to the cis Golgi region.
Recently we localized the mannose-6-phosphate receptor for
lysosomal enzymes in several secretory and absorptive cell
types by immunocytochemistry in an attempt to define the
Man-6-P-dependent transport route and to identify the site at
which sorting of lysosomal enzymes and secretory products
takes place (1). We localized the receptor in cis Golgi cisternae,
in coated vesicles, and in endosomes and lysosomes ofseveral
cell types. We have assumed that this distribution delineates
the Man-6-P-dependent pathway by which lysosomal en-
zymes are delivered to lysosomes, and that the organelles
mentioned represent stations along this pathway which cor-
respond to the sorting site, the carrier, and the delivery site,
respectively. On the basis of these results we proposed that
normally lysosomal enzymes bearing the recognition marker
are removed from the secretory pathway in the cis Golgi for
delivery to lysosomes, bypassing the trans Golgi cisternae.
Our previous findings applied to the steady-state distribu-
tion of Man-6-P receptors in several epithelia (hepatocytes,
exocrine pancreas, and epididymis) in which the polarity of
the Golgi stacks (cis vs. trans) is clear. In this paper, we have
extended our inquiry to cultured cells and have determined
the distribution of the receptor both at steady state (untreated
cells) and under conditions in which the traffic of lysosomal
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enzymes is perturbed by tunicamycin (2, 3) or chloroquine
(3-6) treatment. In cells incubated with these agents, sorting
oflysosomal enzymes does not take place owing either to the
production of defective ligand (2, 3) or to a deficiency of
receptors (6), respectively. As a result, in both instances the
newly synthesized lysosomal enzymes are secreted ratherthan
being delivered to lysosomes (2-6).
MATERIALS AND METHODS
Materials:
￿
Flab) fragments of goat anti-rabbit IgG conjugated to rho-
daminewere purchased from Cappel Laboratories, Inc., (Cochranville, PA)and
F(ab) fragments ofsheep anti-rabbit IgG conjugated to horseradish peroxidase
were obtained from the Institute Pasteur Productions (Marnes La Coquette,
France). Diaminobenzidine hydrochloride (Type II), tunicamycin, cyclohex-
amide, chloroquine, and saponin were purchased from Sigma Chemical Co.,
(St. Louis, MO). Clone 9 and Fu5C8 cells (rat hepatocyte cell lines) were
obtained from Dr. David Sabatini, New York University (3), and normal rat
kidney (NRK) cells were obtained from Dr. Ira Pastan, National Institutes of
Health.
Cell Culture:
￿
Cells were cultured at 37°C in Eagle's minimal essential
medium, containing 10% fetal calfserum, 1% penicillin, and I % streptomycin
in an atmosphere of 95% 02, 5% C02. They were grown on coverslips for
immunofuorescence and in 35-mm plastic dishes to near confluency for
immunoelectron microscopy. Agents that induce lysosomal enzyme secretion
were added to the incubation media for 3 h before fixation at the same
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cycloheximide, 2 Kg/ml ; chloroquine, 25 pM .
Preparation of Antibodies:
￿
Procedures for the preparation and
affinity purification of anti-Man-6-P receptor IgG, designated R2, were given
previously (1). Briefly, the Man-6-P receptor, a 215-kdalton protein (7, 8) was
affinity purified from a detergent extract of rat liver microsomal membranes
on a pentamannosyl-6-phosphate column . Antibodies were raised against this
protein which specifically immunoprecipitated only the -215-kdalton receptor
protein from radiolabeled rat tissues .
Immunofluorescence : Cultured cells were fixed on coverslips in
3.7% formalin in PBS, pH 7 .4, for 45 min at room temperature, both with and
without acetone permeabilization . They were incubated for 1 h with (a) R2
anti-Man-6-P receptor IgG (40 gg/ml), (b) affinity-purified R2 IgG (10 jg/ml),
or (c) R2 preimmune serum (diluted 1 :100) followed by incubation with
rhodamine-conjugated goat anti-rabbit F(ab) (1:50) and examined in a Zeiss
photomicroscope 11, equipped with epifluorescence illumination and an appro-
priate filter for rhodamine.
Immunoperoxidase :
￿
Clone 9 cells were processed as previously de-
scribed (9) . Briefly, they were fixed in McLean and Nakane's (10) fixative (2%
formaldehyde, 0.75 M lysine, 10 mM Nal04 in phosphate buffer, 35 mM, pH
6.2) for 2-4 h, permeabilized with 0.005% saponin (11) and incubated for 1 h
each in R2 antireceptor IgG or preimmune serum (as detailed above for
immunofluorescence) and horseradishperoxidase-conjugated sheepanti-rabbit
Fab (1 :50) . Cells were then fixed for 1 h in 1 .5% glutaraldehyde in 100 mM
sodium cacodylate, pH 7 .4, containing 5% sucrose, incubated in diaminoben-
zidine hydrochloride (DAB) medium (0.2% DAB with 0.01% H202) for 3-5
min, and postfixed with ferrocyanide-reduced Os0< for 45 min at 4°C . They
were then dehydrated and detached from the plastic dishes by being rinsed
rapidlyin 100% propylene oxide (12), collected in a Pasteurpipette, transferred
to Eppendorf tubes, and centrifuged; the resultant pellets were embedded in
Epon 812 . Thin sections were stained with lead citrate and examined in a
Philips 301 electron microscope .
RESULTS
Localization of Man-6-P Receptors
by lmmunofluorescence
When nonpermeabilized, control (untreated) Clone 9 cells
were incubated with antireceptorantibodies, a uniform, bright
punctate staining was observed (Fig. 1 A), indicating the pres-
ence of cell surface Man-6-P receptors. When cells were
permeabilized with acetone before the antibody incubation, a
punctate intracellular staining was seen which was concen-
trated in the juxtanuclear or Golgi region (Fig. 1 B) .
In cells treated with tunicamycin (Fig . 1 C) or cyclohexi-
mide (Fig . 1 D), no morphological changes were detected by
phase-contrast microscopy. By immunofluorescence the re-
ceptors were seen to be concentrated at the cell surface and
in the juxtanuclear, Golgi region as in controls. However, the
staining pattern in the Golgi region was altered in that instead
of a punctate pattern, the receptors were distributed in a
reticular network of various shapes and sizes . A similar redis-
tribution of receptors was seen in NRK cells, human skin
fibroblasts, and Fu5C8 hepatocytes after tunicamycin treat-
ment .
In cells treated with chloroquine, large cytoplasmic vacuoles
were visible by phase-contrast microscopy (Fig . 1 E). These
vacuoles are assumed to be lysosomes because chloroquine
treatment is known to cause lysosomal vacuolation (13) and
increased intralysosomal pH (14, 15) . By immunofluores-
cence (Fig . 1 F), the distribution of receptors was seen to be
dramatically altered in that instead of being confined to the
Golgi region, it was found throughout the cytoplasm, where
it corresponded to that of the vacuolated lysosomes, many
(but not all) of which were brightly fluorescent at their pe-
riphery.
No staining was seen in cells incubated with R2 preimmune
serum .
FIGURE 1
￿
Immunofluorescence localization of Man-6-P receptors
in Clone 9 hepatocytes . (A) Nonpermeabilized control . A punctate
staining pattern is seen at the cell surface . Receptorsare also present
on the remaining cell surface which is out of the plane of focus .
(B-F) Acetone-permeabilized cells . (B) Control, untreated cell .
Bright punctate staining is limited to the juxtanuclear or Golgi
region . (C and D) Cells treated for 3 h with tunicamycin and
cycloheximide, respectively . Receptors are distributed in a reticular
instead of a punctate pattern in the Golgi region . (E and F) Cell
incubated with chloroquine for 3 h . By phase-contrast microscopy
(E) large vacuolated lysosomes characteristic of chloroquine-treated
cells (13) fill the cytoplasm . By immunofluorescence (F) it is evident
that receptor staining is found at the periphery of some of the large
lysosomes . x 300.
Localization of Man-6-P Receptors by
Immunoelectron Microscopy
In untreated Clone 9 cells, receptors were detected in coated
pits and vesicles located at or near the cell surface (Fig . 2) by
immunoperoxidase . The concentration of receptors in coated
vesicles exposed at the cell surface undoubtedly accounts for
the punctate, surface staining seen by immunofluorescence
and resembles the situation in hepatocytes in situ where
receptors were localized in coated pits along the sinusoidal
plasmalemmal domain (1) . Intracellularly, immunoreactive
receptors were localized in the following : (a) cis Golgi cister-
nae, (b) some of the coated vesicles found near, or budding
from, the reactive Golgi cisternae (Figs . 3 and 4), and (c) in
large reactive vacuoles (0.4-1 .0 jAm), assumed to be lysosomes
or endosomes,' which were typically located in the Golgi
'The large immunoreactive vacuoles could represent either endo-
somes or lysosomes. Because there is no way to distinguish between
these two types oforganelles based on morphology alone, we consider
them collectively here as a group.
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￿
Immunoperoxidase localization of Man-6-P receptors in
coated pits (cp) and coated vesicles (cv) present along the plasma-
lemma of control (untreated) Clone 9 hepatocytes . Note that little
or no staining is present along the remaining (noncoated) regions
of the cell surface . x 43,000 .
region . The rough endoplasmic reticulum, nuclear envelope,
and other cell compartments did not stain for the receptor.
Within the Golgi complex, receptors were typically con-
fined to one or two of the flattened cisternae located on one
side ofthe Golgi stacks, with no apparent gradation ofreaction
product between highly reactive and nonreactive cistemae . In
these cells, as in the case of other cultured cells studied to
date (e.g., normal human fibroblasts and I cell fibroblasts
[9]), it was difficult to determine whether the immunoreactive
cisternae were located on the cis or trans side of the Golgi
stack owing to the absence of appropriate landmarks such as
forming secretory granules. However, insome cases centrioles
were present in the plane of section, and based on their
topography, the reactive cistemae could be identified as cis
cisternae (see Figs . 8 and 9) .
In cells treated with tunicamycin or cycloheximide two
major differences in receptor distribution were found (Figs .
5-9) : (a) The number of Golgi-associated coated vesicles that
contained reaction product was greatly increased, and in some
cases massive accumulations of reactive coated vesicles were
seen near or in continuity with the labeled (cis) cisterna (Fig .
7) ; and (b) staining was rarely seen in lysosomes or endosomes
(Figs . 5-9) . The lack of lysosomal staining was not due to the
absence of these organelles because vacuoles (0.4-1 .0 tam),
which morphologically resemble endosomes or lysosomes,
were present (Figs . 5 and 9). Apparently the change in the
Golgi staining pattern from punctate to reticular detected by
immunofluorescence was created by the lining up ofimmu-
noreactive coated vesicles along Golgi cisternae together with
the loss of punctate endosomal or lysosomal staining . It is of
interest that the receptor distribution was the same in tuni-
camycin- and cycloheximide-treated cells: in both cases label-
ing of the Golgi stack was restricted to one or two cisternae,
there was no visible gradation of staining between reactive
and nonreactive cisternae, and when sections through the
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Golgi complex included the centrioles (Figs. 8 and 9), the
reactive cisternae could be identified as cis cistemae .
Chloroquine treatment also induced striking changes in the
distribution of Man-6-P receptors : (a) immunoreactive recep-
tors were found almost exclusively in huge (1-3 tam) vacuo-
lated endosomes or lysosomes, and (b) they were not usually
detected in Golgi cisternae or in coated vesicles (Figs . 10 and
11). Only rarely was a small amount of reaction product
detected ina single Golgi cisterna or in a coated vesicle . Most
often those structures were unstained .
DISCUSSION
There isnow abundant evidence that the interaction between
phosphomannosyl residues on newly synthesized lysosomal
enzymes and Man-6-P receptors results in the selective tar-
geting of lysosomal enzymes to lysosomes (6, 16). Although
some cell types lack Man-6-P receptors (17), there is no doubt
that Man-6-P receptors are widely distributed and functional
in most cell types tested to date (16-18). We have previously
shown by immunocytochemistry (1) that at steady state the
highest intracellular concentrations of Man-6-P receptors-
the key element in the sorting process-are in cis Golgi
cisternae, in some coated vesicles, and in endosomes and/or
lysosomes in several cell types (hepatocytes, exocrine pan-
creatic, and epididymal epithelia) studied in situ .
In this report we have determined the distribution of the
receptor in cultured cells under conditions, established by
previous investigators (2, 3, 6), in which the traffic of lysoso-
mal enzymes is perturbed by tunicamycin and chloroquine
treatments, and the enzymes are not sorted for delivery to
lysosomes but are secreted into the medium . We found that
both treatments lead to a redistribution of receptors : in tuni-
camycin- (or cycloheximide-) treated cells, receptors are found
in coated vesicles lined up at the presumptive sorting site in
the cis Golgi and are not detected in lysosomes and endo-
somes, whereas in chloroquine-treated cells receptors are
found at the presumptive delivery site (endosomes or lyso-
somes) and are not detected in Golgi cisternae .
The redistribution of receptors that occurs after tunicamy-
cin treatment can be explained by the fact that in the presence
of this N-glycosylation inhibitor the recognition marker is not
added to lysosomal enzymes; hence the enzymes fail to bind
to the receptor for sorting and delivery to lysosomes and are
secreted into the medium (2, 3) along with other secretory
products. The receptor-bearing coated vesicles which nor-
mally serve as the carrier to ferry the acid hydrolases from the
cis Golgi to lysosomes return to the sorting site in the cis
Golgi where they gradually accumulate over time, awaiting
the arrival of an appropriate ligand.
The redistribution ofreceptorsthat occurs after chloroquine
treatment can be explained by the fact that in the presence of
this lysosomotropic agent, receptors become trapped in lyso-
FIGURES 3-7
￿
Immunoperoxidase localization of Man-6-13 receptors in the Golgi regions (G) of Clone 9 hepatocytes . In controls
(Figs . 3 and 4), immunoreactive receptors are highly concentrated in one or two Golgi cisternae (1 and 2) located on one side of
the stack, in coated vesicles (cv) located near the reactive cisternae, and in 0.4-1 .0-tam vacuoles (v) that presumably correspond
to endosomes or lysosomes . In tunicamycin-treated (3 h) cells (Figs . 5 and 6), there is a dramatic accumulation of coated vesicles
(arrows) in the Golgi region (G), and no immunoreactive endosomes or lysosomes (v) are seen. As in controls, immunoreactive
receptors are concentrated in one or two Golgi cisternae located on one side of the stacks . Fig. 7 is a higher magnification of
another tunicamycin-treated cell, demonstrating receptors in coated vesicles close to (cv) or in continuity with (cv') a reactive
Golgi cisterna . Note that reaction product is found in only one or two of the Golgi cisternae, and there is no gradation of reaction
product across the stack . (Figs . 3 and 4) x 24,000; (Fig . 5) x 18,000; (Fig . 6) x 16,500; (Fig . 7) x 40,000 .
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￿
Figs . 8and 9 demonstrate the effects of cycloheximide-treatment (3 h) on Clone 9 hepatocytes . As in tunicamycin-
treated cells, immunoreactive coated vesicles (cv) accumulate in the Golgi region and in one or two Golgi cisternae but are not
detected in endosomes or lysosomes (v) . Fortuitously, in both figures the sections pass through the centrioles (c) which can be
used as topographical markers for the trans side of the Golgi stack : immunoreactive Golgi cisternae are located on the opposite
or cis side of the stacks . Note that the degree and direction of curvature of the Golgi stacks is quite variable . Figs. 10 and 11
demonstrate the effects of chloroquine treatment (3 h) on the distribution of Man-6-P receptors . Receptors are detected in huge
(1-3 /Am) lysosomes or endosomes (Ly), and the Golgi cisternae (Cc) are virtually depleted of immunoreactive receptors . Also,
relatively few of the Golgi-associated coated vesicles (cv) contain immunoreactive receptors. (Figs . 8 and 9) x 23,000; (Fig. 10)
x 20,000 ; (Fig. 11) x 26,000.
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6-P receptors when the pH rises above 6.0 (6). Chloroquine
is known to increase intralysosomal pH (and presumably also
intraendosomal pH) to > 6.0 (13, 14). Under these conditions
the carrier coated vesicles, containing lysosomal enzymes
bound to the receptor (19), continue to fuse with lysosomes,
causing an accumulation of receptors in these organelles.
Thus, the receptors are not found in any new or different
intracellular sites (e.g., transGolgi or GERL [Golgi-associated
endoplasmic reticulum lysosome] cisternae) under the con-
ditions studied. Instead, it appears that there is a redistribution
of the receptors along the normal delivery route with these
treatments causing a depletion ofreceptors from some stations
on the presumptive route and an accumulation at others.
The finding ofincreased numbers of coated vesicles bearing
Man-6-P receptors in the Golgi region in tunicamycin- (and
cyclohexamide-) treated cells is the same as observed previ-
ously (9) in I cell fibroblasts from patients with Mucolipidosis
II which are also ligand deficient. I cells are the functional
equivalent of tunicamycin-treated cells in that they do not
make the recognition marker (owing to a deficiency in N-
acetyl glucosamine phosphotransferase) (20, 21), and they
secrete rather than store newly synthesized lysosomal enzymes
(22). We previously noted(9) that the accumulation of coated
vesicles in ligand-deficient cells implies that there is a distinc-
tive subpopulation of coated vesicles involved as primary
lysosomes in the transport of lysosomal enzymes from the cis
Golgi to lysosomes and that ligand loading must trigger their
relocation to lysosomes. The present results with chloroquine
suggest that dissociation of the ligand triggers return of the
receptors (presumably via coated vesicles) to the cis Golgi.
Based on the presence of immunoreactive receptors in cis
Golgi cisternae and their absence from the remaining Golgi
cisternae, we previously proposed (1) that the cis Golgi rep-
resents the site where the secretory and lysosomal pathways
diverge and that normally the bulk of the intracellular lyso-
somal enzymes bearing the recognition marker are sorted for
delivery to lysosomes in the cis Golgi, bypassing the trans
Golgi cisternae. We further proposed that if sorting does not
occur because of the lack of functional receptors or ligand,
acid hydrolases continue along the secretory pathway, reach
the trans Golgi cisternae where the appropriate enzymes are
believed to reside (23-25), and are trimmed, and at leastsome
of their oligosaccharide chains undergo further processing to
the complex type (addition of terminal galactose and sialic
acid). The results obtained on Clone 9 hepatocytes are in
keeping with this proposal since Rosenfeld et al. (3) have
demonstrated that in these cells, all of the intracellular, pre-
cursor acid hydrolases contain high-mannose (endoglycosi-
dase [Endo] H-sensitive) type oligosaccharides, whereas those
that are normally secreted (30-40% of the total synthesized)
contain complex-type (Endo H-resistant and Endo D-sensi-
tive) oligosaccharides. Thus, both the biochemical findings
on the glycosylation state of the secreted enzymes in Clone 9
cells, as well as the present observations on the distribution
ofMan-6-P receptors after treatments that perturb lysosomal
enzyme traffic, are in accord with the assumption that sorting
of the bulk of the acid hydrolases normally occurs in the cis
Golgi. Alternative explanations, e.g., that the bulk ofthe Man-
6-P-dependent intracellular sorting occurs in transGolgi(26-
28) or GERL (29, 30) elements, are more difficult to reconcile
with the information at hand.
Are there some general principles in Golgi sorting to be
learned from our findings? With great foresight, Sly and co-
workers (6, 16, 31) predicted that the intracellular sorting of
acid hydrolases for delivery to lysosomes occurs by a receptor-
mediated "segregation" event comparable to receptor-me-
diated endocytosis at the cell surface, which removes them
from the biosynthetic pathway. They also predicted (6) that
the secretion of lysosomal enzymes by chloroquine-treated
cells occurs as the result of the accumulation of Man-6-P
receptors in lysosomes and their depletion from the endo-
plasmic reticulum or Golgi. Our findings document that this
is indeed the case. Furthermore, our results pinpoint the
location of the receptor-mediated event to cis Golgi cisternae
and identify the carrier as a coated vesicle subpopulation
whose membranes must be compositionally distinct from
endocytic vesicles at the cell surface. It might be predicted
that sorting of other cell products destined for other cell
surfaces (e.g., basal instead of luminal) and membrane con-
stituents destined for specific cell compartments might occur
by a similar receptor-mediated process in a distinctive sub-
population of coated vesicles which removes them from the
appropriate region of the Golgi complex by means of as-yet-
unidentified specific receptors. An interesting case in point is
the Man-6-P receptor-itselfan integral membrane glycopro-
tein with N-asparagine-linked, complex-type oligosaccharides
(32, 33)-which must be specifically targeted to cis Golgi
cisternae.
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